Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Jan 2026 for Acura Pharmaceuticals, INC.
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
George K. Ross: trading record in brief
This profile gathers the share dealings of George K. Ross in Acura Pharmaceuticals, Inc, where the filings describe the role as board member. Between 23 August 2011 and 2 January 2026, the trades on record add up to 16 filings.
Every open-market trade on record is a purchase: 2 purchases worth €11k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 12 option exercises.
On 15 January 2026 came the latest disclosure, an option exercise in Acura Pharmaceuticals, Inc. The most recent open-market purchase was published on 18 December 2017, 3,232 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to George K. Ross
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
50,000 sharesCommon StockSEC:0001104659-26-004048:0
50,000 sharesCommon StockSEC:0001104659-25-006020:0
50,000 sharesCommon StockSEC:0001104659-24-000290:0
66,666 sharesCommon StockSEC:0001104659-23-001406:0
66,666 sharesCommon StockSEC:0001104659-22-002725:0
8,074 sharesCommon StockSEC:0001209191-16-088589:0
6 of 6 declarations
